Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Personalizing Treatment Selection
A key opinion leader in dermatology explains how the presence of type 2 inflammation informs their treatment decisions for atopic dermatitis and prurigo nodularis, while also detailing additional patient-specific factors such as age, comorbidities, and disease severity that influence their therapeutic approach.
EP: 1.Navigating the Challenges of Respiratory Diseases
EP: 2.The Impact of Atopic Dermatitis and Prurigo Nodularis
EP: 3.Linking Type 2 Inflammation to Asthma and COPD
EP: 4.Impact of Exacerbations in Type 2 Inflammatory Respiratory Diseases
EP: 5.Type 2 Inflammation: The Link Between AD and PN
Now Viewing
EP: 6.Personalizing Treatment Selection
EP: 7.Navigating Treatment Challenges in Chronic Skin Conditions
EP: 8.Role of Biologics in Dermatological Care
EP: 9.Biomarkers as Tools in Management of Type 2 Inflammation
EP: 10.Strategies to Manage Type 2 Inflammation in Respiratory Diseases
EP: 11.Addressing Unmet Needs and Emerging Agents
EP: 12.Future Directions for Type 2 Inflammation Management
EP: 13.Type 2 Inflammatory Diseases and Impact on Quality of Life
EP: 14.Type 2 Inflammation Biomarkers
EP: 15.How Type 2 Inflammation Influences Treatment Choices
EP: 16.Complications of Uncontrolled Disease and Management of Comorbidities
EP: 17.Patient Education and Emerging Therapies
EP: 18.Unmet Needs and Future Research
- How does knowing that type 2 inflammation is a cause influence your treatment selection?
- Beyond identifying the underlying cause, what other patient-specific factors (e.g., age, comorbidities, disease severity) do you consider when selecting treatment regimens for AD or PN?
Related Videos
Related Content
